{"created":"2023-06-19T09:12:21.289480+00:00","id":24177,"links":{},"metadata":{"_buckets":{"deposit":"c01dd8cb-f984-47d6-8bad-e2ce816a91b4"},"_deposit":{"created_by":127,"id":"24177","owners":[127],"pid":{"revision_id":0,"type":"depid","value":"24177"},"status":"published"},"_oai":{"id":"oai:kumadai.repo.nii.ac.jp:00024177","sets":["343:347:348:349"]},"author_link":[],"item_14_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2009-03-25","bibliographicIssueDateType":"Issued"}}]},"item_14_date_granted_74":{"attribute_name":"学位授与年月日","attribute_value_mlt":[{"subitem_dategranted":"2009-03-25"}]},"item_14_degree_grantor_72":{"attribute_name":"学位授与機関","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_language":"ja","subitem_degreegrantor_name":"熊本大学"}],"subitem_degreegrantor_identifier":[{"subitem_degreegrantor_identifier_name":"17401","subitem_degreegrantor_identifier_scheme":"kakenhi"}]}]},"item_14_degree_name_71":{"attribute_name":"学位名","attribute_value_mlt":[{"subitem_degreename":"博士（医学）","subitem_degreename_language":"ja"}]},"item_14_description_5":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"アンギオテンシンⅡタイプ1(AT1)受容体ブロッカー(ARB)が糖尿病の新規発症を減少させることが報告され、糖尿病での有用性が注目されている。今回、肥満・2型糖尿病マウス(db/db マウス)におけるチアゾリジン系薬剤とARB の併用療法の意義について検討した。","subitem_description_language":"ja","subitem_description_type":"Other"}]},"item_14_dissertation_number_75":{"attribute_name":"学位授与番号","attribute_value_mlt":[{"subitem_dissertationnumber":"甲第1711号"}]},"item_14_publisher_36":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"熊本大学","subitem_publisher_language":"ja"}]},"item_14_subject_20":{"attribute_name":"日本十進分類法","attribute_value_mlt":[{"subitem_subject":"377.5","subitem_subject_scheme":"NDC"}]},"item_14_text_78":{"attribute_name":"コメント","attribute_value_mlt":[{"subitem_text_language":"ja","subitem_text_value":"熊本大学大学院医学教育部　病態制御学専攻"}]},"item_14_text_81":{"attribute_name":"学位番号","attribute_value_mlt":[{"subitem_text_language":"ja","subitem_text_value":"甲博医第1711号"}]},"item_14_version_type_19":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"福田, 仁也","creatorNameLang":"ja"},{"creatorName":"フクダ, マサヤ","creatorNameLang":"ja-Kana"},{"creatorName":"Fukuda, Masaya","creatorNameLang":"en"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2020-03-02"}],"displaytype":"detail","filename":"22-1711.pdf","filesize":[{"value":"1.3 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"22-1711.pdf","url":"https://kumadai.repo.nii.ac.jp/record/24177/files/22-1711.pdf"},"version_id":"5f118e45-5d47-4c7b-b356-42693dca8cd0"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"糖尿病","subitem_subject_language":"ja","subitem_subject_scheme":"Other"},{"subitem_subject":"PPARγ アゴニスト","subitem_subject_language":"ja-Kana","subitem_subject_scheme":"Other"},{"subitem_subject":"db/db マウス","subitem_subject_language":"ja-Kana","subitem_subject_scheme":"Other"},{"subitem_subject":"インスリン","subitem_subject_language":"ja-Kana","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"thesis","resourceuri":"http://purl.org/coar/resource_type/c_46ec"}]},"item_title":"肥満、2型糖尿病の心血管・腎合併症とインスリン抵抗性に対する PPARγアゴニストとアンギオテンシンⅡ受容体拮抗薬の併用療法の有用性","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"肥満、2型糖尿病の心血管・腎合併症とインスリン抵抗性に対する PPARγアゴニストとアンギオテンシンⅡ受容体拮抗薬の併用療法の有用性","subitem_title_language":"ja"},{"subitem_title":"ヒマン 2ガタ トウニョウビョウ ノ シンケッカン ジン ガッペイショウ ト インスリン テイコウセイ ニ タイスル PPARγ アゴニスト ト アンギオテンシン II ジュヨウタイ キッコウヤク ノ ヘイヨウ リョウホウ ノ ユウヨウセイ","subitem_title_language":"ja-Kana"},{"subitem_title":"Efficacy of Combination Therapy of Peroxisome Proliferator-activated Receptor-gamma Agonist and Angiotensin II Type1 Receptor Blocker Against Cardiovascular and Renal Complication in Obesity and Type2 Diabetes","subitem_title_language":"en"}]},"item_type_id":"14","owner":"127","path":["349"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2010-11-09"},"publish_date":"2010-11-09","publish_status":"0","recid":"24177","relation_version_is_last":true,"title":["肥満、2型糖尿病の心血管・腎合併症とインスリン抵抗性に対する PPARγアゴニストとアンギオテンシンⅡ受容体拮抗薬の併用療法の有用性"],"weko_creator_id":"127","weko_shared_id":-1},"updated":"2026-01-08T00:47:14.719362+00:00"}